You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 19, 2024

Chartwell Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHARTWELL, and what generic and branded alternatives to CHARTWELL drugs are available?

CHARTWELL has five hundred and thirty-six approved drugs.

There are three tentative approvals on CHARTWELL drugs.

Summary for Chartwell

US Patents:	0
Tradenames:	360
Ingredients:	338
NDAs:	536

Drugs and US Patents for Chartwell

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell	FENOFIBRATE (MICRONIZED)	fenofibrate	CAPSULE;ORAL	211407-002	Jan 31, 2024	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	206227-002	Jan 25, 2024	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	RUFINAMIDE	rufinamide	SUSPENSION;ORAL	214009-001	Nov 7, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	040196-002	Sep 30, 1997		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	BENZONATATE	benzonatate	CAPSULE;ORAL	210562-002	Nov 9, 2018		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	087918-001	Dec 22, 1983		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	ENALAPRIL MALEATE	enalapril maleate	TABLET;ORAL	075048-001	Aug 22, 2000		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Chartwell

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chartwell Rx	LIMBITROL DS	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	016949-002	Approved Prior to Jan 1, 1982	4,316,897	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-008	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Molecular	MYKROX	metolazone	TABLET;ORAL	019532-001	Oct 30, 1987	4,517,179	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-006	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-004	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-007	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	LIMBITROL	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	016949-001	Approved Prior to Jan 1, 1982	4,316,897	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.